As the healthcare industry relies more on digital technologies, cybercriminals are also getting ready to exploit the opportunity. @VishalSalvi, Infosys, talks about the ways to overcome #cybersecurity challenges in healthcare industry. https://t.co/w9kBbjkIEC
BY Infosys
Importantly, that investor viewpoint is not new. It cycles in when conditions are right (and vice versa). It also brings the ineffective warnings of an overpriced market with it.Looking toward a good 2022 stock market, there is no apparent reason to expect these issues to change.
However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.
Infosys from kr